SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
119 hedge funds and large institutions have $229M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
-17
Holders Change %
-12.5%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
46
Reduced
37
Closed
29
Calls
$615K
Puts
$416K
Net Calls
+$199K
Net Calls Change
+$85K
Top Buyers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
+$15.4M |
| 2 |
Renaissance Technologies
New York
|
+$3.02M |
| 3 |
Millennium Management
New York
|
+$2.85M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$2.46M |
| 5 |
RA
Royce & Associates
New York
|
+$2.32M |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.61M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$3.59M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.45M |
| 4 |
Morgan Stanley
New York
|
-$2.44M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.35M |
